3/14
08:08 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
3/14
08:08 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
3/14
07:39 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
3/14
07:39 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
3/13
05:21 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
3/13
05:21 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
3/13
04:40 pm
nams
NewAmsterdam Pharma initiated with bullish view at Scotiabank
Low
Report
NewAmsterdam Pharma initiated with bullish view at Scotiabank
3/13
04:40 pm
nams
NewAmsterdam Pharma initiated with bullish view at Scotiabank
Low
Report
NewAmsterdam Pharma initiated with bullish view at Scotiabank
2/29
12:08 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
2/29
12:08 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS